{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:07:40Z","timestamp":1761584860944,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.intimp.2008.07.010","type":"journal-article","created":{"date-parts":[[2008,8,16]],"date-time":"2008-08-16T12:15:51Z","timestamp":1218888951000},"page":"1715-1720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Recovery of IFN-\u03b3 levels in PBMCs from lepromatous leprosy patients through the synergistic actions of the cytokines IL-12 and IL-18"],"prefix":"10.1016","volume":"8","author":[{"given":"Rocio Ivette","family":"Lopez Roa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Guerrero Vel\u00e1squez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anabell","family":"Alvarado Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Montoya Buelna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Garcia Niebla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Fafutis Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2008.07.010_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.1998.tb08309.x","article-title":"Immunomodulatory properties of interferon-gamma. An update","volume":"856","author":"Billiau","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.intimp.2008.07.010_bib2","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1034\/j.1398-9995.1999.00099.x","article-title":"Biologic functions of the IFN-gamma receptors","volume":"54","author":"Tau","year":"1999","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.intimp.2008.07.010_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1473-3099(04)01203-4","article-title":"Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae","volume":"4","author":"van de Vosse","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.intimp.2008.07.010_bib4","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4049\/jimmunol.168.3.1146","article-title":"Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1","volume":"168","author":"Nakahira","year":"2002","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2008.07.010_bib5","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.4049\/jimmunol.176.12.7180","article-title":"Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells","volume":"176","author":"Nembrini","year":"2006","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.intimp.2008.07.010_bib6","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","article-title":"IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production","volume":"161","author":"Yoshimoto","year":"1998","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2008.07.010_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4049\/jimmunol.177.1.234","article-title":"IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway","volume":"177","author":"Maxwell","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2008.07.010_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0952-7915(99)00051-5","article-title":"The role of IL-18 in innate immunity","volume":"12","author":"Akira","year":"2000","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2008.07.010_bib9","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.4049\/jimmunol.166.5.3075","article-title":"The production of IFN-gamma by IL-12\/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4","volume":"166","author":"Schindler","year":"2001","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.intimp.2008.07.010_bib10","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.4049\/jimmunol.160.8.3642","article-title":"IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes","volume":"160","author":"Barbulescu","year":"1998","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2008.07.010_bib11","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.4049\/jimmunol.165.12.6803","article-title":"Stat4 regulates multiple components of IFN-gamma-inducing signaling pathways","volume":"165","author":"Lawless","year":"2000","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2008.07.010_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-4362.1999.00650.x","article-title":"Leprosy: pathogenesis updated","volume":"38","author":"Abulafia","year":"1999","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.intimp.2008.07.010_bib13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1365-4362.2001.01259.x","article-title":"Leprosy: accessory immune system as effector of infectious, metabolic, and immunologic reactions","volume":"40","author":"Abulafia","year":"2001","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.intimp.2008.07.010_bib14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1172\/JCI119162","article-title":"Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy","volume":"99","author":"Libraty","year":"1997","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.intimp.2008.07.010_bib15","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.intimp.2008.07.010_bib16","first-page":"1","article-title":"Chemotherapy of leprosy for control programmes","volume":"675","year":"1982","journal-title":"W H O Tech Rep Ser"},{"key":"10.1016\/j.intimp.2008.07.010_bib17","first-page":"7","article-title":"Separation of leukocytes from blood and bone marrow. Introduction","volume":"97","author":"Boyum","year":"1968","journal-title":"Scand J Clin Lab Invest Suppl"},{"issue":"2","key":"10.1016\/j.intimp.2008.07.010_bib18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4049\/jimmunol.138.2.570","article-title":"T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors","volume":"138","author":"Mohagheghpour","year":"1987","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2008.07.010_bib19","first-page":"320","article-title":"A century of progress in experimental leprosy","volume":"41","author":"Rees","year":"1973","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"5567","key":"10.1016\/j.intimp.2008.07.010_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/262399a0","article-title":"Growth of Mycobacterium leprae and M. marinum in congenitally athymic (nude) mice","volume":"262","author":"Colston","year":"1976","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2008.07.010_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"Scollard","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.intimp.2008.07.010_bib22","first-page":"480","article-title":"Response to phytohemagglutinin of LL patients' lymphocytes preincubated in culture media","volume":"59","author":"Fafutis-Morris","year":"1991","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"3","key":"10.1016\/j.intimp.2008.07.010_bib23","first-page":"566","article-title":"Deficiency in the biosynthesis of interleukin 2 (IL-2) and functional presence of the IL-2 receptor in lepromatous leprosy","volume":"55","author":"Islas-Rodriguez","year":"1987","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"4\u20135","key":"10.1016\/j.intimp.2008.07.010_bib24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0171-2985(11)80443-2","article-title":"Cytokine patterns at the site of mycobacterial infection","volume":"191","author":"Sieling","year":"1994","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.intimp.2008.07.010_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0902-97","article-title":"Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae","volume":"32","author":"Ottenhoff","year":"2002","journal-title":"Nat Genet"},{"issue":"7 Suppl","key":"10.1016\/j.intimp.2008.07.010_bib26","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/00003246-200107001-00008","article-title":"Role of toll-like receptors in inflammatory response in macrophages","volume":"29","author":"Aderem","year":"2001","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.intimp.2008.07.010_bib27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nm864","article-title":"Activation and regulation of Toll-like receptors 2 and 1 in human leprosy","volume":"9","author":"Krutzik","year":"2003","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.intimp.2008.07.010_bib28","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.4049\/jimmunol.162.10.6114","article-title":"IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection","volume":"162","author":"Garcia","year":"1999","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2008.07.010_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4049\/jimmunol.167.2.779","article-title":"A role for IL-12 receptor expression and signal transduction in host defense in leprosy","volume":"167","author":"Kim","year":"2001","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.intimp.2008.07.010_bib30","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4049\/jimmunol.149.4.1470","article-title":"Cytokine patterns of immunologically mediated tissue damage","volume":"149","author":"Yamamura","year":"1992","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2008.07.010_bib31","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1128\/IAI.69.5.3413-3417.2001","article-title":"Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment","volume":"69","author":"Little","year":"2001","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.intimp.2008.07.010_bib32","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.intimp.2008.07.010_bib33","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.177.7.4662","article-title":"IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection","volume":"177","author":"Lockhart","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.intimp.2008.07.010_bib34","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.4049\/jimmunol.178.6.3786","article-title":"IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette\u2013Guerin infection","volume":"178","author":"Umemura","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2008.07.010_bib35","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.177.3.1416","article-title":"Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection","volume":"177","author":"Cruz","year":"2006","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2008.07.010_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1521-6942(02)00127-4","article-title":"Geographically specific infections and arthritis, including rheumatic syndromes associated with certain fungi and parasites, Brucella species and Mycobacterium leprae","volume":"17","author":"McGill","year":"2003","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.intimp.2008.07.010_bib37","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4049\/jimmunol.175.2.788","article-title":"IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available","volume":"175","author":"Khader","year":"2005","journal-title":"J Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908002282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908002282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:05:00Z","timestamp":1761584700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576908002282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":37,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1567576908002282"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2008.07.010","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recovery of IFN-\u03b3 levels in PBMCs from lepromatous leprosy patients through the synergistic actions of the cytokines IL-12 and IL-18","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2008.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}